In turn, transfecting miR-24-1 inhibitor can suppress FBP1 expression (Supplementary Figures 1A, B) and promotes the proliferation and growth of RCC cells (Supplementary Figures 1C, D). This evidence concerns the gene FBP1 and renal cell carcinoma.